Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

There still remain several unanswered questions regarding exudative AMD treatment regimens, including the interval by which "treat and extend" protocols should be extended at each visit ...

Therefore, oral RTK inhibitors are not likely to be used for the long-term treatment of exudative AMD. Monoclonal antibodies generally produce fewer side effects than RTK inhibitors, but because ...

Kalaris Therapeutics, Inc. has completed its merger with AlloVir, positioning itself to advance the development of TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative ...

There are a lot of options out there, but picking an AMD graphics card makes a lot of sense, especially if you don’t want to fork over a lot of extra money for gimmicky extras. All of AMD’s ...

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment ...

The authors commented that the patient’s "age, relative acute onset, and lack of medical history make this an atypical presentation.” Investigators published a recent case report 1 that described the ...

Investigators published a recent case report 1 that described the development of bilateral retinal detachments in a teenager. The patient was an otherwise healthy 19-year-old man who had been referred ...

The closing of the merger is expected to occur as soon as practicable, subject to the satisfaction or waiver of the remaining customary closing conditions. Kalaris Therapeutics, Inc. and AlloVir, ...